Keyphrases
Amyloid Precursor Protein
100%
HIV-associated
100%
Neuronal Damage
100%
β-site APP-cleaving Enzyme 1 (BACE1)
100%
Excitotoxic
100%
Neurotoxicity
27%
N-methyl-D-aspartate Receptor (NMDAR)
27%
HIV-associated Neurocognitive Disorders
27%
Plaque
18%
HIV+ Patients
18%
Induced Toxicity
9%
Monocyte-derived Macrophages
9%
Neuronal Loss
9%
Alzheimer's Disease
9%
Supernatant
9%
Therapeutic Potential
9%
HIV Patients
9%
Alzheimer's Disease Model
9%
Neuroprotective
9%
Neuropathology
9%
Cytotoxicity
9%
Amyloidogenic Processing
9%
Amyloid-precursor
9%
Cognitive Decline
9%
Neuropathogenesis
9%
Alzheimer's Disease Pathology
9%
Common Symptoms
9%
BACE1 Protein
9%
Toxic Species
9%
Dependent Components
9%
Protein Cleavage
9%
Genetic Loss
9%
Mouse Neuron
9%
Protein Knockout
9%
BACE1 Inhibitor
9%
Rat Neurons
9%
BACE1 Inhibition
9%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus
100%
Amyloid Precursor Protein
100%
N-Methyl-D-Aspartic Acid
18%
Genetics
9%
Macrophage
9%
Animal Model
9%
Enzyme
9%
Posttranslational Modification
9%
Cytotoxicity
9%
Supernatant
9%
Beta-Secretase 1
9%
Protein Cleavage
9%
Amyloid Protein
9%
Immunology and Microbiology
Precursor
100%
Human Immunodeficiency Virus
100%
Macrophage
9%
Cytotoxicity
9%
Protein Processing
9%
Supernatant
9%
Protein Cleavage
9%
In Vitro
9%